Innovative Eyewear Inc: receives Nasdaq notice of bid price noncompliance

What happened Innovative Eyewear, Inc. reported that on Oct 9, 2026 it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price of its common stock had closed below $1.00 per share for 30 consecutive business days. The notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market.

Key details (bullet points)

• The Company has 180 calendar days, until Apr 7, 2027, to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5810(c)(3)(A).
• To regain compliance the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during the 180-day period, unless Nasdaq exercises its discretion to extend that period under Rule 5810(c)(3)(H).
• If the Company does not regain compliance by Apr 7, 2027 it may be eligible for an additional 180-calendar day compliance period if it meets Nasdaq’s initial listing criteria (other than the minimum bid price) and the continued listing requirement for market value of publicly held shares, and provides written notice to Nasdaq of an intention to cure the deficiency by effecting a reverse stock split, if necessary.
• If Nasdaq determines the Company will not be able to cure the deficiency or the Company is not eligible for a second period, Nasdaq will provide written notice that the common stock is subject to delisting; the Company may request a hearing before the Nasdaq Hearings Panel, which, if timely, would stay further suspension or delisting pending the hearing.

Why it may matter This filing reports Item 3.01: notice of delisting or failure to satisfy a continued listing rule or standard. Item 3.01 covers Nasdaq’s notice that the Company does not meet the minimum bid price requirement and the procedures and time frames for regaining compliance or pursuing a hearing. A filing does not show why the insider traded or why the company acted.